Stay updated on Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; a minor site version change that does not affect study data or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe revision history shows a new entry for v3.4.1 and the removal of v3.4.0 from the study record history; this is a log-level update and does not alter core study information or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary is now shown and changes are highlighted with green for additions and red for deletions in the record history. The revision label updated to v3.4.0 includes No FEAR Act Data changes.SummaryDifference0.9%

- Check42 days agoChange DetectedThe history now includes revision v3.3.4, and revision v3.3.3 has been removed.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Revision: v3.3.3 is added, and HHS Vulnerability Disclosure and Revision: v3.3.2 are removed from the page history.SummaryDifference0.2%

- Check92 days agoChange DetectedA new revision entry (v3.3.2) was added and an earlier revision (v3.2.0) removed, reflecting page versioning rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.